Dudediligence.

Calidi Biotherapeutics, Inc

CLDIAMEX · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$5.1MSep ’24−$4.1MDec ’24−$5.0MMar ’25−$5.7MJun ’25−$5.1MSep ’25−$4.1MDec ’25−$4.1MMar ’26−$4.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$45,000none on filenone on filenone on file
Operating incomenone on file−$23.1M−$29.0M−$21.8M−$20.2M
Net incomenone on file−$25.4M−$29.2M−$22.1M−$19.9M
Operating cash flownone on file−$13.2M−$27.0M−$19.7M−$21.3M
Cash$1.1M$590,000$2.2M$9.8M$5.8M
Debtnone on file$5.4M$2.9M$3.8M$690,000
Shares outstanding23.0M8.6M3.6M1.7M7.2M